PATENT CLAIM ANALYSIS

Application Number: 16218122
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "211090"]

Abstract:
The present disclosure relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with an HDAC, e.g., HDAC6, having a Formula I: where R, L, X 1 , X 2 , X 3 , X 4 , Y 1 , Y 2 , Y 3 , and Y 4  are described herein.

Claim (Index 56):
The compound of  claim 55 , wherein R is optionally substituted aryl or optionally substituted heteroaryl.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 98.0
- Lexical Diversity: 1.47826
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15013820', '15013814', '15013816', '16218126', '15013826']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8134382542525898
- 35 USC 102 Novelty (BERT): 0.5822631314362295
- Combined Prediction Score: 0.7903207419709537
- Mean Citation Score: 476.19844400000005
- Max Citation Score: 488.61356
- Similarity Product: 400.09584549050567

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test